X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (96) 96
adult (78) 78
hematology (75) 75
index medicus (65) 65
female (61) 61
male (60) 60
middle aged (57) 57
adolescent (51) 51
aged (49) 49
prognosis (39) 39
oncology (37) 37
young adult (34) 34
minimal residual disease (32) 32
acute lymphoblastic leukemia (31) 31
chemotherapy (31) 31
treatment outcome (31) 31
leukemia (27) 27
precursor cell lymphoblastic leukemia-lymphoma - therapy (27) 27
therapy (27) 27
acute lymphoblastic-leukemia (25) 25
cancer (24) 24
abridged index medicus (22) 22
acute lymphocytic-leukemia (22) 22
recurrence (22) 22
antineoplastic agents - therapeutic use (21) 21
remission induction (20) 20
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (19) 19
transplantation (19) 19
aged, 80 and over (18) 18
precursor cell lymphoblastic leukemia-lymphoma - genetics (18) 18
stem cell transplantation (18) 18
acute lymphocytic leukemia (17) 17
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (17) 17
adults (16) 16
stem-cell transplantation (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
clinical-significance (15) 15
precursor cell lymphoblastic leukemia-lymphoma - mortality (15) 15
relapse (15) 15
survival analysis (15) 15
acute myeloid-leukemia (14) 14
hematopoietic stem cell transplantation (14) 14
stem cells (14) 14
acute lymphatic leukemia (13) 13
hemic and lymphatic diseases (13) 13
immunophenotyping (13) 13
lymphatic leukemia (13) 13
precursor cell lymphoblastic leukemia-lymphoma - pathology (13) 13
risk factors (13) 13
survival (13) 13
blinatumomab (12) 12
clinical trials as topic (12) 12
combined modality therapy (12) 12
disease-free survival (12) 12
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (12) 12
standard-risk (12) 12
adult patients (11) 11
gene expression (11) 11
inotuzumab ozogamicin (11) 11
remission (11) 11
antibodies, bispecific - therapeutic use (10) 10
childhood (10) 10
neoplasm, residual (10) 10
precursor b-cell lymphoblastic leukemia-lymphoma - mortality (10) 10
prognostic factors (10) 10
survival rate (10) 10
antibodies, bispecific - adverse effects (9) 9
antineoplastic agents - adverse effects (9) 9
children (9) 9
clinical trials (9) 9
drug resistance, neoplasm (9) 9
hematology, oncology and palliative medicine (9) 9
medicine & public health (9) 9
patients (9) 9
prospective studies (9) 9
research (9) 9
salvage therapy (9) 9
age factors (8) 8
analysis (8) 8
antineoplastic agents - administration & dosage (8) 8
care and treatment (8) 8
chronic myeloid-leukemia (8) 8
kaplan-meier estimate (8) 8
mutation (8) 8
quantification (8) 8
bone-marrow-transplantation (7) 7
expression (7) 7
follow-up (7) 7
genes (7) 7
germany (7) 7
hematopoietic stem cells (7) 7
lymphocytes b (7) 7
medicine (7) 7
mrd (7) 7
polymerase-chain-reaction (7) 7
precursor b-cell lymphoblastic leukemia-lymphoma - pathology (7) 7
precursor b-cell lymphoblastic leukemia-lymphoma - therapy (7) 7
precursor t-cell lymphoblastic leukemia-lymphoma - genetics (7) 7
prognostic-significance (7) 7
transplantation, homologous (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Journal Article
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, ISSN 0080-0015, 2020, Volume 214, p. 71
Bispecific T cell engagers are antibody constructs directed to a tumor-specific target on the one hand and to CD3-positive T cells on the other hand.... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 740 - 753
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2016, Volume 2016, Issue 1, pp. 573 - 579
The treatment of older patients with acute lymphoblastic leukemia (ALL) is an unmet medical need. With increasing age, ALL patients have a significantly lower... 
Immunotherapy - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Humans | Aged, 80 and over | Female | Male | Aged | Clinical Trials as Topic | Health Services for the Aged | Optimizing Treatments for High-Risk Acute Lymphoblastic Leukemia | What It Takes to Move the Needle
Journal Article
Drugs & Aging, ISSN 1170-229X, 01/2018, Volume 35, Issue 1, p. 11
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 02/2017, Volume 142, Issue 3, pp. 170 - 175
Was ist neu? Diagnostik und Risikofaktoren  Die Bedeutung konventioneller Risikofaktoren tritt im Verhältnis zu der prognostischen Relevanz des individuellen... 
Klinischer Fortschritt
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Journal Article
Hematology, ISSN 1520-4391, 2016, Volume 2016, Issue 1, pp. 573 - 579
The treatment of older patients with acute lymphoblastic leukemia (ALL) is an unmet medical need. With increasing age, ALL patients have a significantly lower... 
SURVIVAL | ADULT PATIENTS | IMATINIB | BLINATUMOMAB | DASATINIB | INDUCTION | STEM-CELL TRANSPLANTATION | HEMATOLOGY | ELDERLY-PATIENTS | EDUCATION, SCIENTIFIC DISCIPLINES | CHEMOTHERAPY | AGE
Journal Article
Der Onkologe, ISSN 0947-8965, 07/2017, Volume 23, Issue 7, pp. 522 - 531
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 09/2017, Volume 30, Issue 3, pp. 261 - 274
Journal Article
Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 02/2017, Volume 142, Issue 3, pp. 170 - 175
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2006, pp. 133 - 141
Journal Article
Der Onkologe, ISSN 0947-8965, 07/2017, Volume 23, Issue 7, p. 522
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00761-017-0236-4... 
Tyrosine | Chemotherapy | Stem cells | Transplantation | Acute lymphocytic leukemia | Drug therapy | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2235 - 2235
To the Editor: In their article on Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) in children, adolescents, and young adults, Roberts... 
MEDICINE, GENERAL & INTERNAL | KINASE | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Female | Male | Animals | Protein Kinase Inhibitors - therapeutic use | Humans | Adolescence | Acute lymphatic leukemia | Lymphocytes B | Older people | Leukemia | Children | Lymphatic leukemia | Gene expression | Philadelphia chromosome
Journal Article